A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

Last updated: October 9, 2024
Sponsor: Sanofi
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gaucher Disease

Treatment

N/A

Clinical Study ID

NCT04845958
OBS16092
U1111-1267-2545
  • Ages < 18
  • All Genders

Study Summary

Primary Objective:

To assess prevalence of Gaucher disease (GD) diagnosed in pediatric patients presenting with unexplained splenomegaly (SMG) after exclusion of first intention-diagnoses (e.g. portal hypertension, haematological malignancy, hemolytic anemia, infection) based on clinical examination and routine biological tests (full blood count, reticulocytes, liver tests, abdominal ultrasound, Coombs test and Epstein Barr virus serology).

Secondary Objectives:

  • To describe the rate of each identified disease category and the rate of patients with no final diagnosis at the end of the study in pediatric patients with unexplained SMG after exclusion of first intention diagnoses

  • To describe the characteristics (clinical, lab, genetics) of all pediatric patients included in the study and to describe the characteristics subdivided by identified disease category and absence of final diagnosis at the end of the study

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Patient under the age of 18 years

  • Patient with unexplained SMG (SMG defined as a palpable spleen, already known ordiscovered for the first time) and who has undergone tests to eliminate obviouscauses of SMG

Exclusion

Exclusion criteria:

Patient with any obvious cause of SMG as described by clinical examination and/or lab or imaging test available in medical records and/or having been diagnosed with any of the following conditions:

  1. hemolytic anemia

  2. hematological malignancy

  3. portal hypertension

  4. infectious disease associated with SMG (Cytomegalovirus, Epstein Barr virus,leishmaniasis or other obvious infectious cause revealed by the medical history)

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study Design

Total Participants: 150
Study Start date:
June 30, 2021
Estimated Completion Date:
September 24, 2025

Study Description

The planned duration of this study is 39 months, which includes 36 months of patient recruitment.

Connect with a study center

  • Investigational Site Number 2500036

    Amiens, 80054
    France

    Active - Recruiting

  • Investigational Site Number 2500014

    Angers, 49933
    France

    Active - Recruiting

  • Investigational Site Number 2500034

    Argenteuil, 95107
    France

    Active - Recruiting

  • Investigational Site Number 2500039

    Bayonne, 64100
    France

    Active - Recruiting

  • Investigational Site Number 2500015

    Besançon, 25030
    France

    Active - Recruiting

  • Investigational Site Number 2500003

    Bordeaux, 33000
    France

    Active - Recruiting

  • Investigational Site Number 2500038

    Brest, 29609
    France

    Active - Recruiting

  • Investigational Site Number 2500026

    Caen, 14033
    France

    Active - Recruiting

  • Investigational Site Number 2500018

    Chambéry, 73000
    France

    Active - Recruiting

  • Investigational Site Number 2500009

    Clermont-Ferrand, 63000
    France

    Active - Recruiting

  • Investigational Site Number 2500008

    Colombes, 92700
    France

    Active - Recruiting

  • Investigational Site Number 2500028

    Créteil, 94000
    France

    Active - Recruiting

  • Investigational Site Number 2500006

    Dijon, 21079
    France

    Active - Recruiting

  • Investigational Site Number 2500010

    Gleizé, 69400
    France

    Active - Recruiting

  • Investigational Site Number 2500031

    Jossigny, 77600
    France

    Active - Recruiting

  • Investigational Site Number 2500040

    La Rochelle, 17000
    France

    Active - Recruiting

  • Investigational Site Number 2500007

    La Tronche, 38700
    France

    Active - Recruiting

  • Investigational Site Number 2500030

    Limoges, 87042
    France

    Active - Recruiting

  • Investigational Site Number 2500001

    Lyon, 69008
    France

    Active - Recruiting

  • Investigational Site Number 2500032

    Mantes-la-Jolie, 78200
    France

    Active - Recruiting

  • Investigational Site Number 2500005

    Marseille, 13005
    France

    Active - Recruiting

  • Investigational Site Number 2500027

    Meaux, 77100
    France

    Active - Recruiting

  • Investigational Site Number 2500002

    Montpellier, 34090
    France

    Active - Recruiting

  • Investigational Site Number 2500021

    Nantes, 44000
    France

    Active - Recruiting

  • Investigational Site Number 2500019

    Nice, 06200
    France

    Active - Recruiting

  • Investigational Site Number 2500022

    Nîmes, 30029
    France

    Active - Recruiting

  • Investigational Site Number 2500016

    Paris, 75012
    France

    Active - Recruiting

  • Investigational Site Number 2500013

    Perpignan, 66000
    France

    Active - Recruiting

  • Investigational Site Number 2500035

    Poissy, 78300
    France

    Active - Recruiting

  • Investigational Site Number 2500011

    Poitiers, 86000
    France

    Active - Recruiting

  • Investigational Site Number 2500029

    Reims, 51100
    France

    Active - Recruiting

  • Investigational Site Number 2500023

    Rennes, 35203
    France

    Active - Recruiting

  • Investigational Site Number 2500037

    Roubaix, 59056
    France

    Active - Recruiting

  • Investigational Site Number 2500024

    Rouen, 76031
    France

    Active - Recruiting

  • Investigational Site Number 2500017

    Saint-Priest-en-Jarez, 42270
    France

    Active - Recruiting

  • Investigational Site Number 2500004

    Strasbourg, 67200
    France

    Active - Recruiting

  • Investigational Site Number 2500033

    Toulouse,
    France

    Active - Recruiting

  • Investigational Site Number 2500020

    Tours,
    France

    Active - Recruiting

  • Investigational Site Number 2500025

    Valenciennes, 59300
    France

    Active - Recruiting

  • Investigational Site Number 2500012

    Vandœuvre-lès-Nancy, 54500
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.